R&D | March 20, 2026
NIPER Raebareli–Roche tie-up signals big push for India’s pharma innovation future
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
The aim is to strengthen industry-academia cooperation
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Subscribe To Our Newsletter & Stay Updated
